BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,079 filers reported holding BAXTER INTL INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $2,469,000 | -28.6% | 28,224 | -33.1% | 0.06% | -28.6% |
Q2 2019 | $3,456,000 | +22.6% | 42,196 | +21.7% | 0.08% | +18.3% |
Q1 2019 | $2,818,000 | +208.3% | 34,664 | +149.6% | 0.07% | +173.1% |
Q4 2018 | $914,000 | -26.0% | 13,888 | -13.3% | 0.03% | -10.3% |
Q3 2018 | $1,235,000 | +0.6% | 16,016 | -3.7% | 0.03% | -9.4% |
Q2 2018 | $1,228,000 | -32.2% | 16,632 | -40.2% | 0.03% | -34.7% |
Q1 2018 | $1,810,000 | -27.2% | 27,832 | -27.7% | 0.05% | -26.9% |
Q4 2017 | $2,487,000 | -55.3% | 38,472 | -56.6% | 0.07% | -58.6% |
Q3 2017 | $5,568,000 | -17.9% | 88,732 | -20.8% | 0.16% | -20.6% |
Q2 2017 | $6,782,000 | +62.3% | 112,028 | +39.1% | 0.20% | +59.4% |
Q1 2017 | $4,178,000 | +19.8% | 80,556 | +2.4% | 0.13% | +11.3% |
Q4 2016 | $3,487,000 | – | 78,652 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |